(KEMX) KraneShares MSCI Emerging - Ratings and Ratios

The KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) is an exchange-traded fund that focuses on mid- and large-cap companies in emerging markets, excluding China. By doing so, it provides investors with targeted exposure to the growth potential of emerging economies without the influence of Chinese markets.

Under normal circumstances, KEMX invests at least 80% of its assets in instruments that track its underlying index or have similar economic characteristics. This index is weighted by free float-adjusted market capitalization, meaning it gives more significance to companies with larger market capitalizations that are available for public trading.

From a technical standpoint, KEMX has shown a bullish trend, with its last price of $30.46 being above both its 20-day and 50-day Simple Moving Averages (SMA20 and SMA50) of $29.20 and $28.26, respectively. The Average True Range (ATR) indicates a relatively stable volatility level, with a 1.86% daily average price movement. Given these indicators, a potential forecast could be that KEMX may continue its upward trend if it maintains its position above the SMA20 and SMA50, potentially testing its 52-week high of $31.18.

Fundamentally, KEMX has $67.86 million in Assets Under Management (AUM), indicating a moderate level of investor interest. Emerging markets, excluding China, offer a diverse portfolio of companies across various sectors, potentially benefiting from growth in countries like India, South Korea, and Brazil. If the economic conditions in these countries continue to improve, it could positively impact the funds performance.

Combining technical and fundamental analysis, a forecast for KEMX could be that it maintains its upward trajectory, driven by the growth in emerging markets and supported by its technical indicators. However, investors should be cautious of potential market volatility and global economic shifts that could impact emerging markets. A strategic entry point could be near its SMA20 or SMA50, around $29.20 or $28.26, with a target near its 52-week high of $31.18, while keeping a close eye on the ATR for signs of increasing volatility.